Dihydroxyphenylethylene glycol

From WikiMD's WELLNESSPEDIA

Dihydroxyphenylethylene glycol (DOPEG) is a metabolite of the neurotransmitter norepinephrine. It is produced in the body through the action of the enzyme monoamine oxidase (MAO), which breaks down norepinephrine, releasing DOPEG as a byproduct.

Chemical Structure and Properties[edit]

DOPEG is a phenolic compound, meaning it contains a benzene ring with one or more hydroxyl groups attached. Its chemical formula is C8H11NO3. It is a colorless, crystalline solid that is soluble in water and alcohol.

Biological Role[edit]

In the human body, DOPEG serves as an indicator of norepinephrine activity. High levels of DOPEG in the urine or blood can indicate increased norepinephrine release, which may be associated with certain medical conditions such as pheochromocytoma, a rare tumor of the adrenal gland.

Clinical Significance[edit]

Measurement of DOPEG levels can be used in the diagnosis and monitoring of pheochromocytoma. In addition, elevated DOPEG levels have been observed in patients with Parkinson's disease, suggesting a role for norepinephrine dysfunction in this condition.

Research[edit]

Research into the role of DOPEG and other norepinephrine metabolites in neurological and psychiatric disorders is ongoing. Understanding the pathways of norepinephrine metabolism and the effects of its metabolites could lead to new treatments for conditions such as depression, anxiety, and Parkinson's disease.

See Also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.